National Bank of Canada’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

National Bank of Canada’s Portfolio LMNL Stock Details LMNL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,852	Closed	-$61.1K	–	2920
2023 Q2	$61.1K	Sell	9,852 -1	-0%	-$7	﹤0.01%	1718
2023 Q1	$34.2K	Sell	9,853 -16	-0.2%	-$74	﹤0.01%	1821
2022 Q4	$31.6K	Sell	9,869 -27	-0.3%	-$123	﹤0.01%	1886
2022 Q3	$41K	Hold	9,896	–	–	﹤0.01%	1765
2022 Q2	$49K	Sell	9,896 -19	-0.2%	-$124	﹤0.01%	1775
2022 Q1	$98K	Buy	9,915 +2,000	+25%	+$18.7K	﹤0.01%	1673
2021 Q4	$83K	Buy	+7,915	New	+$119K	﹤0.01%	1686

National Bank of Canada's LMNL Position: Q3 2023 in Review

National Bank of Canada sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q3 2023, closing a stake of 9,852 shares — an estimated $61.1K sold.

National Bank of Canada first reported a position in LMNL in Q4 2021 and held it in 7 quarters. The position peaked at $98K in Q1 2022. 1 fund tracked by Wall St. Rank holds LMNL as of Q3 2023.

National Bank of Canada reported no remaining Liminal BioSciences Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
National Bank of Canada sold 9,852 Liminal BioSciences Inc. Common Shares shares in Q3 2023, an estimated $61.1K.
National Bank of Canada first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2021 and held it in 7 quarters.
National Bank of Canada's Liminal BioSciences Inc. Common Shares position peaked at $98K in Q1 2022.
1 fund tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q3 2023.

Based on National Bank of Canada's 13F filing for Q3 2023, filed 10 Oct 2023.